Butyrate and acetyl‐carnitine inhibit the cytogenetic expression of the fragile X in vitro

Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome

Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481 · see citing works

Sodium butyrate inhibits histone deacetylation in cultured cells

Candido, E. (1978) · Cell · doi:10.1016/0092-8674(78)90305-7 · Cited by 1,036 · see citing works

The inactive X chromosome in female mammals is distinguished by a lack of histone H4 acetylation, a cytogenetic marker for gene expression

Jeppesen, P., & Turner, B. M. (1993) · Cell · doi:10.1016/0092-8674(93)90419-q · Cited by 700 · see citing works

The effect of sodium butyrate on histone modification

Sealy, L. J. (1978) · Cell · doi:10.1016/0092-8674(78)90306-9 · Cited by 691 · see citing works

Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells

Leder, A., & Leder, P. (1975) · Cell · doi:10.1016/0092-8674(75)90107-5 · Cited by 659 · see citing works

A point mutation in the FMR-1 gene associated with fragile X mental retardation

Boulle, K. D., Verkerk, A. J. M. H., Reyniers, E., Vits, L., Hendrickx, J., Roy, B. V., Bos, F. V. D., de Graaff, E., Oostra, B. A., & Willems, P. J. (1993) · Nature Genetics · doi:10.1038/ng0193-31 · Cited by 624 · see citing works

A Short-Term Trial of Butyrate to Stimulate Fetal-Globin-Gene Expression in the β-Globin Disorders

Perrine, S. P., Ginder, G. D., Faller, D. V., Dover, G. H., Ikuta, T., Witkowska, H. E., Cai, S., Vichinsky, E. P., & Olivieri, N. F. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301143280202 · Cited by 434 · see citing works

Fragile X syndrome without CCG amplification has an FMR1 deletion

Gedeon, Á. K., Baker, E., Robinson, H., Partington, M. W., Gross, B., Manca, A., Korn, B., Poustka, A., Yu, S., Sutherland, G. R., et al. (1992) · Nature Genetics · doi:10.1038/ng0892-341 · Cited by 220 · see citing works

Acetylation of histone H4 and its role in chromatin structure and function

Chahal, S. S., Matthews, H. R., & Bradbury, E. M. (1980) · Nature · doi:10.1038/287076a0 · Cited by 185 · see citing works

Fragile sites in human chromosomes as regions of late-replicating DNA

Laird, C. D., Jaffe, E., Karpen, G. H., Lamb, M. M., & Nelson, R. (1987) · Trends in Genetics · doi:10.1016/0168-9525(87)90268-x · Cited by 156 · see citing works

Acetylated histone H4 is preferentially associated with template-active chromatin.

Davie, J., & Candido, E. P. M. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.8.3574 · Cited by 144 · see citing works

FRAGILE X SYNDROME: A UNIQUE MUTATION IN MAN

Nussbaum, R. L., & Ledbetter, D. H. (1986) · Annual Review of Genetics · doi:10.1146/annurev.ge.20.120186.000545 · Cited by 114 · see citing works

Fragile X Syndrome: A Unique Mutation in Man

Nussbaum, R. L. (1986) · Annual Review of Genetics · doi:10.1146/annurev.genet.20.1.109 · Cited by 106 · see citing works

POST-SYNTHETIC MODIFICATIONS OF HISTONE STRUCTURE

Allfrey, V. G. (1977) · Elsevier eBooks · doi:10.1016/b978-0-12-450550-6.50010-5 · Cited by 73 · see citing works

Stimulation of oxidation of mitochondrial fatty acids and of acetate by acetylcarnitine

Siliprandi, N., SILIPRANDI, D., & Ciman, M. (1965) · Biochemical Journal · doi:10.1042/bj0960777 · Cited by 69 · see citing works

Butyrate suppression of position-effect variegation in Drosophila melanogaster

Reeves, R., Mottus, R., & Grigliatti, T. A. (1980) · Molecular and General Genetics MGG · doi:10.1007/bf00270501 · Cited by 58 · see citing works

Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics

Bagni, C., Tassone, F., Neri, G., & Hagerman, R. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63141 · Cited by 321 · see citing works

Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression

Pettegrew, J. W., Levine, J., & McClure, R. J. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000805 · Cited by 304 · see citing works

Synergistic Effect of Histone Hyperacetylation and DNA Demethylation in the Reactivation of the FMR1 Gene

Chiurazzi, P., Grazia Pomponi, M., Pietrobono, R., Bakker, C. E., Neri, G., & Oostra, B. A. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.12.2317 · Cited by 217 · see citing works

Paclitaxel and Cisplatin-induced neurotoxicity: a protective role of acetyl-L-carnitine.

Pisano, C., Pratesi, G., Laccabue, D., Zunino, F., Giudice, P. L., Bellucci, A., Pacifici, L., Camerini, B., Vesci, L., Castorina, M., et al. (2003) · PubMed · Cited by 180 · see citing works

A double‐blind, parallel, multicenter comparison of <scp>L</scp>‐acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys

Torrioli, M. G., Vernacotola, S., Peruzzi, L., Tabolacci, E., Mila, M., Militerni, R., Musumeci, S., Ramos, F. J., Frontera, M., Sorge, G., et al. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32268 · Cited by 100 · see citing works

Differential epigenetic modifications in the FMR1 gene of the fragile X syndrome after reactivating pharmacological treatments

Tabolacci, E., Pietrobono, R., Moscato, U., Oostra, B. A., Chiurazzi, P., & Neri, G. (2005) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201393 · Cited by 92 · see citing works

45S rDNA Regions Are Chromosome Fragile Sites Expressed as Gaps In Vitro on Metaphase Chromosomes of Root-Tip Meristematic Cells in Lolium spp

Huang, J., Ma, L., Yang, F., Fei, S., & Li, L. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002167 · Cited by 90 · see citing works

Acetyl-L-Carnitine prevents and reverts experimental chronic neurotoxicity induced by oxaliplatin, without altering its antitumor properties.

Ghirardi, O., Giudice, P. L., Pisano, C., Vertechy, M., Bellucci, A., Vesci, L., Cundari, S., Miloso, M., Rigamonti, L. M., Nicolini, G., et al. (2005) · PubMed · Cited by 75 · see citing works

The FRAXopathies: Definition, overview, and update

Pirozzi, F., Tabolacci, E., & Neri, G. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.34113 · Cited by 46 · see citing works

Emerging pharmacologic treatment options for fragile X syndrome

Erickson, C. A., Schaefer, T. L., & Davenport, M. H. (2015) · The Application of Clinical Genetics · doi:10.2147/tacg.s35673 · Cited by 43 · see citing works

Autosomal XX sex reversal caused by duplication ofSOX9

Huang, B., Wang, S., Ning, Y., Lamb, A. N., & Bartley, J. A. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19991203)87:4 · Cited by 424 · see citing works

Links between chromatin structure, DNA repair and chromosome fragility

Surrallés, J., Puerto, S., Ramírez, M. J., Creus, A., Marcos, R., Mullenders, L. H. F., & Natarajan, A. T. (1998) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(98)00093-1 · Cited by 37 · see citing works

Effect of CAT or AGG Interruptions and CpG Methylation on Nucleosome Assembly upon Trinucleotide Repeats on Spinocerebellar Ataxia, Type 1 and Fragile X Syndrome*

Mulvihill, D. J., Edamura, K. N., Hagerman, K. A., Pearson, C. E., & Wang, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m413239200 · Cited by 36 · see citing works

Chromatin structure of human chromosomal fragile sites

Wang, Y. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.07.040 · Cited by 34 · see citing works

Fragile sites, chromosomal lesions, tandem repeats, and disease

Mirceta, M., Shum, N., Schmidt, M. H. M., & Pearson, C. E. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.985975 · Cited by 30 · see citing works

Involvement of L-Carnitine in Cellular Metabolism: Beyond Acyl-CoA Transport

Chapela, S. P., Kriguer, N., Fernandez, E., & Stella, C. A. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709790361502 · Cited by 29 · see citing works

Modelling fragile X syndrome in the laboratory setting: A behavioral perspective

Melancia, F., & Trezza, V. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.04.042 · Cited by 29 · see citing works

Modulation of methylation in the FMR1 promoter region after long term treatment with L-carnitine and acetyl-L-carnitine

Pascale, E., Battiloro, E., Reale, G. C., Pietrobono, R., Pomponi, M. G., Chiurazzi, P., Nicolai, R., Calvani, M., Neri, G., & D’Ambrosio, E. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.6.e76 · Cited by 18 · see citing works

Mitochondrial dysfunction in Fragile X syndrome and Fragile X-associated tremor/ataxia syndrome: prospect use of antioxidants and mitochondrial nutrients

Pagano, G., Lyakhovich, A., Pallardó, F. V., Tiano, L., Zatterale, A., & Trifuoggi, M. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09415-7 · Cited by 10 · see citing works

Chromosome breakages associated with 45S ribosomal DNA sequences in spotted snakehead fish Channa punctatus

Singh, M. K., & Barman, A. S. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-2112-z · Cited by 10 · see citing works

Sodium Butyrate Induces Apoptosis in MSN Neuroblastoma Cells in a Calcium Independent Pathway

Rozental, R., Faharani, R., Yu, Y., Johnson, J., Chan, S. O., & Chiu, F. (2004) · Neurochemical Research · doi:10.1007/s11064-004-6886-9 · Cited by 10 · see citing works

L-acetylcarnitine for treating fragile X syndrome

Rueda, J.-R., Guillén, V., Ballesteros, J., Tejada, M., & Solà, I. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010012.pub2 · Cited by 6 · see citing works

The Potential Inhibitory Role of Acetyl-L-Carnitine on Proliferation, Migration, and Gene Expression in HepG2 and HT29 Human Adenocarcinoma Cell Lines

Albogami, S. M. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45030155 · Cited by 5 · see citing works

L-acetylcarnitine for fragile X syndrome

Rueda, J.-R., Guillén, V., Ballesteros, J., Tejada, M., & Solà, I. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010012 · Cited by 1 · see citing works

Acetyl-L-Carnitine in Mood, Aging, and Disease

Pettegrew, J. W., Levine, J., & McClure, R. J. (2002) · Springer eBooks · doi:10.1007/978-1-4615-1067-3_10

Reactivation of the FMR1 Gene

Tabolacci, E., & Chiurazzi, P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804461-2.00017-2

Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells

Coffee, B., Zhang, F., Warren, S. T., & Reines, D. (1999) · Nature Genetics · doi:10.1038/8807 · Cited by 325 · see citing works

Differential epigenetic modifications in the FMR1 gene of the fragile X syndrome after reactivating pharmacological treatments

Tabolacci, E., Pietrobono, R., Moscato, U., Oostra, B. A., Chiurazzi, P., & Neri, G. (2005) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201393 · Cited by 92 · see citing works

The effect of methionine and 5-azacytidine on fragile X expression.

Abruzzo, M. A., Mayer, M., & Jacobs, P. A. (1985) · PubMed · Cited by 11 · see citing works

Modulation of methylation in the FMR1 promoter region after long term treatment with L-carnitine and acetyl-L-carnitine

Pascale, E., Battiloro, E., Reale, G. C., Pietrobono, R., Pomponi, M. G., Chiurazzi, P., Nicolai, R., Calvani, M., Neri, G., & D’Ambrosio, E. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.6.e76 · Cited by 18 · see citing works

Am. J. Hum. Genet. 71:923–932, 2002 Histone Modifications Depict an Aberrantly Heterochromatinized FMR1 Gene in Fragile X Syndrome

Coffee, B. W., Zhang, F., Ceman, S., Warren, S. T., & Reines, D. (2013)